Page Title goes here
short description
Whats New:
February 1, 2012
Latest Article
Pharma Revolution Recalibrated, Pharmaceutical Executive, November 2011
Latest Blog Entry
Bionumbers Index
All Indexes Updated - End January 2012
All Indexes Updated - End January 2012
January was an up-up-month for all indexes and the NASDAQ; Drug Delivery was up 6.6%, Emerging Specialty was up 8.55 and Commercial Stage Specialty was up 2.5% on a much larger base.
DDEP2011 Report
Updated - September 2011
Our DDEP2011 report focuses on Drug Delivery and goes far beyond a simple listing and analysis of product sales. DDEP 2011 analyzes a wide variety of development and commercialization parameters that impact product success. The development parameters include: clinical development times, phase transition rates, success rates, and development costs. Commercialization parameters include: sales and prescriptions, market exclusivity and sales uptake curves. More information on DDEP2011 is available.
Search our Site
Welcome to our sitemap and search web page. Use the search box to find a specific word, term or phrase, or just browse through the list of web pages in our site!
Main Menu
- Home Page
- Services
- Reports & Forecast Tools
- Bionumbers Indexes
- Articles & Blog
- Contact
- Privacy Policy
Products Menu
Contact Us
Drug Delivery Product Strategy and Forecasts
